Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lotus Pharmaceuticals, a manufacturer and seller of medicine and drugs in the People's Republic of China (PRC), has names Xing Shen as the vice president of Corporate Development and Yan Zeng as the chief financial officer of the company.
Subscribe to our email newsletter
As a vice president of Corporate Development, Xing Shen will oversee the company’s strategic business development and internal investor relations functions.
Prior to his tenure with Lotus Pharma, Shen served as an equity analyst at RBC Capital Markets, covering companies in the biotech space.
However, prior to joining Lotus Pharma, Zeng worked as a registered accountant and auditor with Beijing Topson Certified Public Accountants and as a financial manager for Beijing Unite Youbang Science and Technology.
Lotus Pharma chairman and CEO Zhongyi Liu said that by building a solid senior management team with significant industry experience, they are positioning themselves to capture a greater share of the pharmaceutical market in China and sustain a high rate of growth while maintaining internal control.